NCT07084688

Swiss Cardiovascular-Kidney-Liver-Metabolic (CKLM) Registry

• Status: Not Yet Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 1,500 (estimated)
• Sponsor: University Hospital, Basel, Switzerland · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The aim of this clinical and exploratory Swiss Cardiovascular-Kidney-Liver-Metabolic (CKLM) Registry is to establish high quality prevalence and incidence database for Cardiovascular-Kidney-Metabolic (CKM) syndrome, its major contributors, and the extent of the respective organ damaged.

Detailed description

The Swiss Cardiovascular-Kidney-Liver-Metabolic (CKLM) Registry is a prospective, longitudinal, non-interventional registry based at the Medical Outpatient Department of the University Hospital Basel. It aims to address key knowledge gaps related to (I) the prevalence, incidence, and heterogeneity of CKLM syndrome and its clinical phenotypes, (II) liver involvement, (III) emerging therapies, and (IV) the need for interdisciplinary care and integrated management. The registry supports improved understanding and management of this complex syndrome in routine clinical practice.

Conditions

• Cradiovascular-kidney-liver-metabolic (CKLM) Syndrome
• Cardiovascular-kidney-metabolic Syndrome

Timeline

• Start date: 2025-07-14
• Primary completion: 2040-07-01
• Completion: 2040-07-01
• First posted: 2025-07-24
• Last updated: 2025-07-24

Locations

1 site across 1 country: Switzerland